Quantcast
Last updated on April 18, 2014 at 15:29 EDT

Latest Patentability Stories

2014-03-11 23:02:58

The US Patent Office (USPTO) has issued an office action in its re-examination of Bruce Murison’s We-Vibe patent. San Jose, CA (PRWEB) March 11, 2014 The US Patent Office (USPTO) has issued an office action in its re-examination of Bruce Murison’s We-Vibe patent 7,931,605. The office action rejected all of the patent claims-at-issue in the reexamination. The USPTO’s rejection of the We-Vibe patent follows LELO’s request for ex parte reexamination, which LELO filed on October 21...

2013-12-11 20:20:44

The United States Patent & Trademark Office (USPTO) Confirms The Validity of Imagenetix's Patent No. 5,569,676 (Cetyl Myristoleate) SAN DIEGO, Dec. 11, 2013 /PRNewswire/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGXQ), announced today that the Board of Appeals for the United States Patent & Trade Office (USPTO) rejected NIKKEN's effort to invalidate Imagenetix's patent no. 5,569,676 and issued a decision confirming the validity of the patent. On November 27, 2013, Imagenetix...

Steve Jobs Patent Denial Reversed By USPTO
2013-10-19 03:43:03

Michael Harper for redOrbit.com - Your Universe Online The US Patent and Trademark Office (USPTO) has reversed its decision and upheld an Apple multi-touch patent, often called the “Steve Jobs Patent.” The agency reversed the patent last month, but blogger Florian Mueller recently discovered the paperwork detailing the reversal. The late Apple cofounder applied for the patent in 2008 and the USPTO awarded it less than a year later. In the filing Steve Jobs’ name is listed with 24...

2013-10-09 08:34:07

USPTO decision opens the door for patent infringement litigation to resume in court MOUNTAIN VIEW, Calif., Oct. 9, 2013 /PRNewswire/ -- AirTight Networks announced today that the United States Patent and Trademark Office (USPTO) has confirmed the validity of the company's U.S. Patent No. 7,339,914 (the "'914 patent") on October 04, 2013, in a second patent re-examination challenge by competitor Aerohive Networks that claimed the AirTight patent was invalid. With the validity of the...

2013-09-19 23:04:07

U.S. Patent and Trademark Office upheld the SynQor IBA patent in a reexamination requested by Vicor Corporation confirming the ruling against Murata. Boxborough, MA (PRWEB) September 19, 2013 SynQor announced today that the U.S. Patent and Trademark Office (“PTO”) issued an Action Closing Prosecution confirming the patentability of all of the claims in SynQor’s U.S. patent 8,023,290 (the “’290 patent”). These claims relate to unregulated Intermediate Bus Architecture...

2013-09-03 16:27:02

WASHINGTON, Sept. 3, 2013 /PRNewswire-USNewswire/ -- A patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF) "covers ineligible subject matter and was anticipated by and obvious" in view of earlier research, Consumer Watchdog and the Public Patent Foundation have told a federal appeals court. In a reply brief filed late last week in the U.S. Court of Appeals for the Federal Circuit seeking to invalidate the '913 patent issued by the Patent and...

2013-08-20 23:04:21

SynQor announced today that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office upheld the patentability of SynQor's U.S. Patent relating to unregulated Intermediate Bus Architecture. Boxborough, MA (PRWEB) August 20, 2013 SynQor announced today that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office reversed an earlier decision by a patent examiner in an inter partes reexamination proceeding and upheld the patentability of SynQor's...

2013-08-15 16:24:13

SAN DIEGO, Aug. 15, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that the United States Patent and Trademark Office (USPTO), has issued a non-final, initial office action in the Ex Parte Reexamination of US Patent No. 6,028,222, or the '222 patent, one of the two licensed patents covering OFIRMEV(®) (acetaminophen) injection. Although the USPTO made an initial determination to reject certain claims, all of the claims of the '222 patent remain...

2013-06-06 04:20:59

GHENT, Belgium, June 6, 2013 /PRNewswire/ -- The United States Patent and Trade Office (USPTO) has allowed Pronota's patent for the use of a blood-based biomarker LG3 in the decision-making process for the treatment of renal dysfunction. This is a major step forward for Pronota as it reconfirms the patentability of the use of biomarkers. A decision of the US Supreme Court in Mayo vs. Prometheus in March 2012 had questioned the patentability of the use of biomarkers as...

2012-08-14 10:21:26

DALLAS, Aug. 14, 2012 /PRNewswire/ -- TransData Inc., a leading designer and manufacturer of advanced, solid-state power & energy metering products, today announced that the U.S. Patent and Trademark Office (U.S. Patent Office) has issued reexamination certificates confirming the patentability of three TransData patents related to digital electric meters equipped with internal wireless communications. The recent certificates conclude four anonymous patent reexamination requests filed with...